Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Avid Bioservices ( (CDMO) ) has shared an update.
At Avid Bioservices’ 2024 Annual Meeting, stockholders approved significant amendments to the 2018 Omnibus Incentive Plan, adding 3.8 million shares for grants, and the 2010 Employee Stock Purchase Plan, eliminating its automatic termination clause. Additionally, Ernst & Young LLP was ratified as the independent auditor, and all nominated directors were elected. These changes reflect strategic financial decisions aimed at enhancing shareholder value and improving the company’s compensation structure.
Find detailed analytics on CDMO stock on TipRanks’ Stock Analysis page.
